Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-6.06M.
ENTERPRISE VALUE (EV)
$-6.06M
Virax Biolabs Group Limited
Market Cap
$354606.00
Enterprise Value (EV)
$-6.06M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Virax Biolabs Group Limited (VRAX) | $354606.00 | $-6.06M |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | $371977.00 |
| XORTX Therapeutics Inc. (XRTX)vs › | $484571.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $245237.00 | N/A |
| VivoSim Labs, Inc. (VIVS)vs › | $530421.00 | N/A |
| HCW Biologics Inc. (HCWB)vs › | $563178.00 | $6.38M |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109735.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $95097.00 | N/A |
| CDT Equity Inc. (CDT)vs › | $678241.00 | $971.25M |
| PRF Technologies Ltd. (PRFX)vs › | $70876.00 | N/A |
Market Cap
$354606.00
Total Debt
$28477.00
Cash
$6.44M
Enterprise Value
$-6.06M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
